Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Financials
Numis made good progress across its business in FY17, started the current year at a similar pace and has a good pipeline of potential deals. Implementation of MiFID II will affect research and sales income, but the evidence so far points to a moderate rather than severe impact on this part of the business. Trading is subject to market trends but, given the strong start to the year and the further development of the firm’s franchise, we have raised both our estimates and valuation.
Written by
Numis Corporation |
Advancing on all fronts |
FY17 results |
Financial services |
20 December 2017 |
Share price performance
Business description
Next events
Analysts
|
||||||||||||||||||||||||||||||||||||||||||||||||
Numis made good progress across its business in FY17, started the current year at a similar pace and has a good pipeline of potential deals. Implementation of MiFID II will affect research and sales income, but the evidence so far points to a moderate rather than severe impact on this part of the business. Trading is subject to market trends but, given the strong start to the year and the further development of the firm’s franchise, we have raised both our estimates and valuation.
Year end |
Revenue (£m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
09/16 |
112.3 |
32.5 |
22.4 |
12.0 |
14.0 |
3.8 |
09/17 |
130.1 |
38.3 |
25.9 |
12.0 |
12.1 |
3.8 |
09/18e |
132.2 |
38.0 |
27.0 |
12.0 |
11.6 |
3.8 |
09/19e |
137.1 |
39.4 |
28.3 |
12.0 |
11.1 |
3.8 |
Note: *PBT and EPS are on a reported basis.
FY17 results
Revenues for FY17 were up 16%, with both Corporate Broking and Advisory (+15%) and Equities (+17%) contributing strongly. The number of corporate clients increased modestly, now standing at over 200, and their average market capital has increased by 33% to £728m. The median market cap is much lower at £322m and Numis remains committed to its small- and mid-cap stronghold. Equity raised for corporate clients increased by 33%. Within Equities, market-making revenue rose 39% and the strength of the research and sales team contributed to a 12% increase in institutional commissions in the face of continuing pressure on rates. Pre-tax profit rose by 18% to £38.1m and EPS by 15.6% to 25.9p. The dividend was unchanged at 12p and under a revised dividend policy the board intends to pay a stable dividend and return surplus liquidity through share buybacks (see page 4).
Outlook – positive start to FY18
The current year has started well in terms of corporate transactions and the Equities business revenues are running ahead of the prior year. Encouragingly, the feedback on negotiations with institutions related to MiFID II so far suggest a small impact on revenue and a high rate of client retention. This, the continued development of the corporate client base and the achievement of a smooth management succession give confidence on a longer view, even if market volatility interrupts the earnings progression at some point. Our FY18 revenue estimate is increased by 11%, feeding into a 22% increase in EPS.
Valuation
The shares have performed well over the last year (+31%) but are not expensively rated compared with peers and, reflecting our higher estimate, our central ROE/COE-based valuation increases from 323p to 354p.
FY17 results: Progress across the business
In the year to end-September, Numis recorded good growth across its business with overall revenues up 16%. Revenues for both Equities and Corporate Broking and Advisory were at record levels. Pre-tax profits and earnings per share were 17% ahead. The corporate client list now stands at just over 200. Key points were as follows with comparisons against FY16:
■
Revenue increased by 16% to £130.1m.
■
Staff costs rose 17% to £69m, reflecting variable compensation and a 3% increase in the average headcount to 220, while the year-end figure stood at 235 (see Exhibit 1). This reflected selective investment to strengthen capabilities across the company. The compensation ratio for the year was little changed at 53.0% versus 52.4%.
■
Other costs increased by less than 7% and nudged down one point to 19% as a ratio of revenues, leaving the overall cost/income ratio at 71%. As shown in Exhibit 2, these ratios have been broadly stable since FY13.
■
Other operating income (net gains on the strategic investment portfolio) was £3.4m versus £3.8m. Most of the gain this year arose from price movements on quoted holdings, which account for half of the portfolio (largely through the Numis mid-cap fund).
■
Pre-tax profit increased by 18% to £38.1m or, excluding the portfolio gains, by 21% to £34.9m.
■
Earnings per share increased by 16.6% to 27.4p or, on a diluted basis, by 15.6% to 25.9p.
■
The full-year dividend of 12.0p was unchanged and Numis indicates that it has adopted a new stance on dividends and share buybacks (see below).
■
The balance sheet remains strong, with cash increasing from £89.0m to £95.9m after spending £22.9m on share repurchases. There is an estimated regulatory capital surplus of £67m.
■
The number of corporate clients increased by a net 3 to end the year at 202.
■
Equity capital raised for clients was £2.5bn, compared with £1.9bn (+33%), and the 45 equity raisings included 7 IPOs. The Corporate Broking and Advisory business also carried out 37 pure advisory roles, and 17 block trades and sell-downs, with a total value of £0.9m.
■
Numis’s UK equity capital markets share (by calendar year) has risen from 2.6% in 2013 and 9.8% in 2016 to 9.9% at the end of November this year (sources: Numis, Bloomberg).
|
Exhibit 1: Revenue per head and headcount |
Exhibit 2: Cost to revenue ratios |
|
|
|
Source: Numis, Edison Investment Research |
Source: Numis, Edison Investment Research |
|
Exhibit 1: Revenue per head and headcount |
|
|
Source: Numis, Edison Investment Research |
|
Exhibit 2: Cost to revenue ratios |
|
|
Source: Numis, Edison Investment Research |
Exhibit 3 shows the segmental composition of revenue for FY17. Compared with the average for the previous five years, there are two changes: the contribution from institutional commissions is 27% compared with 33%, while placing commissions have risen from 37% to 44%. The changes reflect the particularly strong performance in corporate finance activity as the Numis franchise has expanded over the six years concerned.
Franchise development is further illustrated in Exhibit 4, which shows the progression of total revenues for Numis and the aggregate market capital of its clients. The growth in aggregate market capital reflects both the growth in client numbers and an upward trend in the average market capital, which now stands at £726m, up 28% on the prior year. The development in corporate client base feeds into each of the business areas to a greater or lesser extent. Although the increased scale within the client base is valuable for revenue generation, Numis underlines its continuing commitment to the small cap area, which remains an area of strength for the business. This is reflected in the level of median market capital for its clients that, at £322m, is less than half the average figure.
|
Exhibit 3: Revenue analysis FY17 |
Exhibit 4: Revenue versus client market capital |
|
|
|
Source: Numis |
Source: Numis |
|
Exhibit 3: Revenue analysis FY17 |
|
|
Source: Numis |
|
Exhibit 4: Revenue versus client market capital |
|
|
Source: Numis |
Exhibit 5 shows the development of segmental revenues over the past five years. FY17 trading income showed further strong progress (+39% versus FY16) after a marked step-up in FY16. Numis indicates that the FY17 result was achieved with only a limited increase in capital usage. While institutional commission rates remained under pressure in the run up to MiFID, commission income was up 12%, which can be seen as a reflection of a relatively favourable market background in terms of market levels, a contribution from block trades (on the buyer side) and the strength of the Numis institutional franchise.
Corporate retainers, which we see as a relatively sticky source of income, grew by 20%, reflecting a 5% rise in the average corporate client count together with the benefit of progressive fee increases. The level of advisory fees was stable, but taking pure M&A advisory activity within this (excluding some fees related to capital raisings) the increase would have been 16%.
Exhibit 5: Revenue analysis
£m |
2013 |
2014 |
2015 |
2016 |
2017 |
Change FY17/FY16 |
Net trading gains |
8.5 |
7.7 |
4.1 |
6.5 |
9.0 |
39% |
Institutional commissions |
28.8 |
31.9 |
29.3 |
31.9 |
35.8 |
12% |
Net Institutional Income |
37.2 |
39.6 |
33.4 |
38.4 |
44.8 |
17% |
Corporate retainers |
6.9 |
7.8 |
8.9 |
9.6 |
11.6 |
20% |
Advisory fees |
6.0 |
9.0 |
17.9 |
16.3 |
16.5 |
1% |
Placing commissions |
27.5 |
36.5 |
37.7 |
48.0 |
57.2 |
19% |
Corporate related |
40.4 |
53.3 |
64.6 |
73.9 |
85.3 |
15% |
Total revenue |
77.7 |
92.9 |
98.0 |
112.3 |
130.1 |
16% |
Source: Numis
Dividend and share buyback policy
Numis has indicated an adjustment in its dividend and share buyback policy. Under this, the aim is to pay a stable ordinary dividend (unchanged at 12p for FY17) with consideration given to investing in the business platform, investing in selective growth opportunities and returning surplus cash to shareholders, subject to liquidity and capital requirements and market conditions. The group intends to buy back shares over the medium term to at least offset any prospective dilution from unvested share awards and potentially to reduce the share count further in order to enhance shareholder returns.
Background and outlook
The UK equity market provided a relatively favourable background for equity issuance during Numis’s FY17, with indices following an upward trend for most of the period (Exhibit 6) while volatility was also comparatively low despite unsettling macro developments (Exhibit 7). Explanations put forward for this pattern include the resilience of the UK economy, sterling weakness and the continuation of historically low policy rates.
|
Exhibit 6: FTSE AIM, All-Share and Small Cap indices |
Exhibit 7: FTSE 100 volatility index |
|
|
|
Source: Thomson Datastream. Note: total return series |
Source: Thomson Datastream |
|
Exhibit 6: FTSE AIM, All-Share and Small Cap indices |
|
|
Source: Thomson Datastream. Note: total return series |
|
Exhibit 7: FTSE 100 volatility index |
|
|
Source: Thomson Datastream |
The result has been a strengthening in equity fund-raising (see below) with the value of issuance on the London Stock Exchange Main market up by 6% and AIM by 13% compared with the prior year period. New issuance for both markets was up 27%, while further issuance (over 70% of the total) was only marginally ahead (+2%).
|
Exhibit 8: AIM and Main market value of issuance |
|
|
Source: LSE. Note: for year to end September. |
While low volatility tends to moderate secondary trading activity, the average daily value of trading on the Main market increased by 6% and for the AIM market there was a substantial (88%) rise for FY17 versus FY16.
Numis reports that it has made a strong start to the current year. There have been 11 fund-raisings to date, including the IPOs of Sabre Insurance Group (£575m) and Ero Copper (C$110m), and placings for Hilton Food Group, IP Group, RWS Group, Keywords Studios and Clinigen Group (all to finance M&A). The run rate of revenues in the Equities business is reported as being ahead of the daily rate for FY17.
This is encouraging, but as usual the macro background has considerable uncertainty and a rise in volatility could have an impact on sentiment and the pace of corporate and institutional investor activity. Alternatively, continuation of economic resilience and better than feared progress in the second stage of Brexit negotiations could ease realisation of the promising pipeline of potential transactions that Numis reports.
With MiFID II coming into force in January 2018, the implications of research unbundling for institutional commissions remains a prominent potential sensitivity for Numis, as for other brokers. Numis remained in discussion with institutional clients at the time of the results release and indicated that institutional retention following the process was likely to be very high. The equities team includes 39 analysts covering 17 sectors and c 370 companies, while institutions are also served by 30 salespeople, 10 sales traders and 14 UK market makers. The research team is well-ranked in institutional surveys. Based on current trends, there seems likely to be a modest negative effect on sales and research-related revenues as a result of MiFID II implementation, with reductions in payments from some institutions mitigated to some extent by new payments from private client brokers and the potential for higher execution flow as broker lists are trimmed.
Numis continues to develop its ability to conduct private placements. The Venture Broking team focuses on advising fast-growing private companies and works with a growing pool of seed, venture capital and growth, listed and private equity investors. The team seek to identify promising companies that it can advise and help introduce to potential investors. This area should continue to increase its contribution to revenue over time while providing a source of potential IPO candidates and new corporate clients as its network expands.
Management succession largely complete
A process of management transition is almost complete following the announcement in May 2016 that Oliver Hemsley would step down as CEO. Alex Ham and Ross Mitchinson took on the role of joint CEOs in September 2016. Oliver Hemsley stepped down from the board in May 2017, although he will remain as an adviser until at least May 2018. There has also been a handover of the non-executive chairman’s role, with Alan Carruthers replacing Gerald Corbett in March this year. Still to take place at the beginning of 2018 is the succession in the finance director role, with Andrew Holloway taking over from Simon Denyer. A summary of board changes is shown in Exhibit 9.
The co-CEOs and FD-designate have been at Numis for between eight and 12 years, while most other senior members of the executive team have similar tenure, pointing to continuity while introducing fresh leadership for the next stage in the development of Numis.
Exhibit 9: Prospective board composition and changes
Board members |
Role |
Date of joining |
||
Prospective board following announced changes |
||||
Executive directors |
||||
Alex Ham |
Co-CEO |
Sep-16 |
||
Ross Mitchinson |
Co-CEO |
Sep-16 |
||
Andrew Holloway |
CFO |
Jan-18 |
||
Independent non-executive directors |
||||
Alan Carruthers |
Chairman |
Mar-17 |
||
Geoffrey Vero |
Apr-03 |
|||
Robert Sutton |
May-14 |
|||
Catherine James |
May-14 |
|||
Prospective and recent board departures |
Date stood/standing down |
|||
Oliver Hemsley |
Founder and former CEO remains as adviser at least until May 2018 |
May-17 |
||
Marcus Chorley |
Chairman of equities stepping down from board but remains in current role |
Sep-17 |
||
Lorna Tilbian |
Head of media sector – leaving company December 2017 |
Sep-17 |
||
Simon Denyer |
Group finance director and company secretary – leaving company |
Jan-18 |
||
Source: Edison Investment Research, Numis Corporation
Financials
With the strong trading seen in H217 continuing at a similar rate at the beginning of the current year, we have materially increased our revenue and profit estimates for FY18. We have also introduced an estimate for FY19. In both cases, the normal caveats relating to the sensitivity to market conditions should be borne in mind. Changes in the key figures from our estimates are shown in Exhibit 10 and further details can be seen in the financial summary (Exhibit 13).
The continued progress in building the corporate client base and the early indication of only moderately negative effects from MiFID II on institutional commissions are encouraging signs for Numis’s longer-term growth through market cycles.
Exhibit 10: Estimate revisions
Revenue (£m) |
PBT (£m) |
EPS (p) |
DPS (p) |
|||||||||
Old |
New |
Change |
Old |
New |
Change |
Old |
New |
Change |
Old |
New |
Change |
|
09/17e/a |
129.0 |
130.1 |
0.8% |
36.5 |
38.3 |
5.0% |
25.0 |
25.9 |
3.6% |
12.0 |
12.0 |
0.0% |
09/18e |
119.5 |
132.2 |
10.6% |
30.8 |
38.0 |
23.7% |
22.1 |
27.0 |
22.2% |
12.5 |
12.0 |
-4.0% |
09/19e |
137.1 |
N/A |
39.4 |
N/A |
28.3 |
N/A |
12.0 |
N/A |
||||
Source: Edison Investment Research. Note: for FY17, the ‘old’ column is our estimate and ‘new’ is actual.
Operating cash flow benefited from increased profits and a net realisation of £4.5m from the investment portfolio but, when compared with last year, this was more than offset by broadly unchanged market-making positions in contrast to the significant inflow seen in FY16. As a result, net cash flow from operating activities was somewhat lower at £43.4m, compared with £48.7m for FY16, but this still left room for share repurchases of £22.9m, dividend payments of £13.5m and an increase in cash from £89.0m to £95.9m.
The investment portfolio of strategic investments stood at £28.1m at the year-end, including £14.1m of unquoted investments, £12.4m in the Numis mid-cap fund and £1.6m in listed equities. Net gains on these investments are shown under the other operating income line (£3.4m). The intention is to manage the unlisted investments more actively as Numis looks to provide initial capital and to act as an introducer to follow-on investors, rather than being a longer-term holder itself.
Numis indicates that its qualifying capital stands at £126.7m, while it has an estimated capital requirement including buffer of £60m, leaving a substantial regulatory capital surplus of £67m.
Valuation
We have updated our comparative valuation table below. It includes UK brokers together with a selection of US and European investment banks and advisory firms. The businesses are significantly differentiated but provide a qualified peer group for comparison. In terms of P/Es, Numis is towards the lower end of the range, while both its return on equity and price to book are above average.
Exhibit 11: Peer comparison
Price (local) |
Market cap (£m) |
Last reported PER (x) |
Current PER (x) |
Yield |
Price to book (x) |
ROE |
|
UK brokers |
|||||||
Numis |
314.0 |
340 |
11.5 |
11.6 |
3.8 |
2.6 |
23.1 |
Arden |
53.5 |
17 |
loss |
N/A |
0.0 |
1.8 |
-14.8 |
Cenkos |
108.5 |
62 |
23.1 |
8.8 |
5.5 |
2.2 |
10.0 |
Shore Capital |
207.5 |
45 |
34.6 |
15.8 |
2.4 |
0.8 |
2.3 |
WH Ireland |
120.0 |
33 |
loss |
N/A |
0.0 |
2.4 |
-6.9 |
UK brokers average |
23.0 |
12.1 |
2.4 |
2.0 |
2.7 |
||
US, European IB and advisory |
|||||||
Bank of America |
29.5 |
229,257 |
18.6 |
16.2 |
0.8 |
1.2 |
7.6 |
Evercore |
90.2 |
2,600 |
32.9 |
17.1 |
1.4 |
7.3 |
40.5 |
Goldman Sachs |
256.5 |
74,998 |
15.5 |
13.4 |
1.0 |
1.3 |
10.6 |
Greenhill |
19.5 |
381 |
10.2 |
N/A |
9.3 |
2.0 |
8.1 |
JP Morgan |
106.5 |
275,812 |
17.1 |
15.4 |
1.8 |
1.6 |
10.8 |
Moelis |
47.7 |
2,386 |
26.1 |
20.4 |
7.0 |
7.6 |
25.4 |
Morgan Stanley |
52.9 |
71,417 |
17.8 |
14.9 |
1.3 |
1.4 |
9.5 |
Stifel |
60.3 |
3,082 |
52.0 |
17.3 |
0.0 |
1.5 |
7.8 |
Credit Suisse |
17.6 |
33,920 |
loss |
23.8 |
3.8 |
1.0 |
-3.3 |
Deutsche Bank |
16.8 |
30,661 |
loss |
17.5 |
1.0 |
0.5 |
-0.8 |
UBS |
18.4 |
52,849 |
loss |
14.4 |
0.0 |
1.2 |
7.7 |
US, European IB and advisory average |
23.8 |
17.1 |
2.5 |
2.4 |
11.3 |
||
Source: Bloomberg. Note: priced at 20 December 2017.
For our ROE/COE model, we have used assumptions of an ROE of 21% (equivalent to the 2014-18e average), a cost of equity of 10% and growth of 4%. Applying these to the FY17 NAV gives a central value of 354p (323p previously, with the increase reflecting a higher ROE and NAV base). The sensitivity of this valuation to changing growth and ROE assumptions is illustrated in Exhibit 12.
Exhibit 12: ROE/COE valuation output variations (value per share, p)
Growth rate (right) Return on equity |
2.0% |
3.0% |
4.0% |
5.0% |
6.0% |
12.0% |
156 |
161 |
167 |
175 |
188 |
16.0% |
219 |
232 |
250 |
275 |
313 |
21.0% |
297 |
321 |
354 |
400 |
469 |
24.0% |
344 |
375 |
417 |
475 |
563 |
28.0% |
406 |
447 |
500 |
575 |
688 |
Source: Edison Investment Research
Exhibit 13: Financial summary
£000s |
2015 |
2016 |
2017 |
2018e |
2019e |
||
Year end 30 September |
|||||||
PROFIT & LOSS |
|||||||
Revenue |
|
|
97,985 |
112,335 |
130,095 |
132,157 |
137,063 |
Other operating income |
|
|
(1,978) |
3,759 |
3,431 |
2,000 |
2,000 |
Total income |
|
|
96,007 |
116,094 |
133,526 |
134,157 |
139,063 |
Cost of Sales (excl. amortisation and depreciation) |
(65,018) |
(76,120) |
(83,626) |
(84,962) |
(89,617) |
||
Share based payment |
(4,104) |
(6,229) |
(10,454) |
(10,100) |
(9,000) |
||
EBITDA |
|
|
28,863 |
29,986 |
36,015 |
37,095 |
38,446 |
Depreciation |
|
|
(882) |
(1,126) |
(1,226) |
(1,230) |
(1,230) |
Amortisation |
(111) |
(125) |
(89) |
(33) |
0 |
||
Operating Profit |
|
|
27,870 |
28,735 |
34,700 |
35,832 |
37,216 |
Net finance income |
190 |
37 |
188 |
195 |
205 |
||
Other operating income |
(1,978) |
3,759 |
3,431 |
2,000 |
2,000 |
||
Profit Before Tax |
|
|
26,082 |
32,531 |
38,319 |
38,027 |
39,421 |
Tax |
(4,533) |
(6,132) |
(7,942) |
(7,887) |
(8,249) |
||
Profit after tax (FRS 3) |
|
|
21,549 |
26,399 |
30,377 |
30,140 |
31,171 |
Average diluted number of shares outstanding (m) |
117.6 |
118.0 |
117.2 |
111.5 |
110.0 |
||
EPS - basic (p) |
19.5 |
23.5 |
27.4 |
28.7 |
30.1 |
||
EPS - diluted (p) |
|
|
18.3 |
22.4 |
25.9 |
27.0 |
28.3 |
Dividend per share (p) |
11.50 |
12.00 |
12.00 |
12.00 |
12.00 |
||
NAV per share (p) |
102.0 |
113.5 |
125.0 |
138.9 |
154.3 |
||
ROE (%) |
19% |
22% |
23% |
22% |
20% |
||
EBITDA margin (%) |
29.5% |
26.7% |
27.7% |
28.1% |
28.0% |
||
Operating margin (before GW and except.) (%) |
28.4% |
25.6% |
26.7% |
27.1% |
27.2% |
||
BALANCE SHEET |
|||||||
Fixed assets |
|
|
6,724 |
5,522 |
6,147 |
5,384 |
4,654 |
Current assets |
|
|
279,114 |
312,462 |
407,850 |
421,338 |
435,922 |
Total assets |
|
|
285,838 |
317,984 |
413,997 |
426,722 |
440,576 |
Current liabilities |
|
|
(170,319) |
(188,895) |
(280,371) |
(280,371) |
(280,371) |
Long term liabilities |
0 |
(12) |
0 |
0 |
0 |
||
Net assets |
|
|
115,519 |
129,077 |
133,626 |
146,351 |
160,205 |
CASH FLOW |
|||||||
Operating cash flow |
|
|
6,467 |
48,735 |
43,369 |
36,203 |
36,091 |
Net cash from investing activities |
(3,632) |
84 |
(198) |
(200) |
(190) |
||
Net cash from (used in) financing |
(17,510) |
(19,580) |
(36,359) |
(27,515) |
(26,317) |
||
Net cash flow |
|
|
(14,675) |
29,239 |
6,812 |
8,488 |
9,584 |
Opening net (cash)/debt |
|
|
(74,518) |
(59,591) |
(89,002) |
(95,852) |
(104,340) |
FX effect |
|
|
(252) |
172 |
38 |
0 |
0 |
Closing net (cash)/debt |
|
|
(59,591) |
(89,002) |
(95,852) |
(104,340) |
(113,924) |
Source: Edison Investment Research
|
|
Research: Investment Companies
Vietnam Enterprise Investments (VEIL) was launched in 1995 and is the largest and longest established, closed-ended investment company, which is focused on Vietnam listed equities. VEIL is listed on the LSE and became a member of the FTSE 250 in July 2017. It has a capital growth objective, managed by an experienced and well-resourced investment team, following a disciplined bottom-up, fundamental approach to stock selection, resulting in a portfolio of c 35-40 holdings. Although Vietnam equities have performed strongly over the past two years, the manager believes the government’s pipeline of privatisations and divestments over the next two years offers excellent investment opportunities, which could continue to attract foreign and domestic investors.